{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:49:56Z","timestamp":1776653396410,"version":"3.51.2"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Journal of Biological Sciences"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.sjbs.2021.05.062","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:16:56Z","timestamp":1622247416000},"page":"5359-5363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of blood groups with hepatitis C viremia"],"prefix":"10.1016","volume":"28","author":[{"family":"Mahnoor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoona","family":"Noreen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Imran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sher Zaman","family":"Safi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Amjad","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afrah Fahad","family":"Alkhuriji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suliman Yousef","family":"Alomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan Mualla","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.sjbs.2021.05.062_bib207","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/vim.2016.0109","article-title":"Oncogenic Role of Tumor Viruses in Humans","volume":"30","author":"Akram","year":"2017","journal-title":"Viral Immunology"},{"issue":"4","key":"10.1016\/j.sjbs.2021.05.062_b0005","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.180257","article-title":"The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses","volume":"5","author":"Al Kanaani","year":"2018","journal-title":"R. Soc. Open Sci."},{"issue":"3","key":"10.1016\/j.sjbs.2021.05.062_bib206","first-page":"1","article-title":"Prevalence of Hepatitis B and Hepatitis C Infection among Patients Undergoing Dialysis","volume":"3","author":"Anwar","year":"2016","journal-title":"Journal of Human Virology & Retrovirology"},{"issue":"6","key":"10.1016\/j.sjbs.2021.05.062_b0010","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/jvh.12864","article-title":"Characterizing the temporal evolution of the hepatitis C virus epidemic in Pakistan","volume":"25","author":"Ayoub","year":"2018","journal-title":"J. Viral Hepat."},{"issue":"7","key":"10.1016\/j.sjbs.2021.05.062_b0020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.sjbs.2021.05.062_b0025","first-page":"99","volume":"20","author":"Bhattacharya","year":"1978","journal-title":"ABO blood groups as related genetic variants of hyperlipidaemia"},{"issue":"4","key":"10.1016\/j.sjbs.2021.05.062_b0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2013Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.sjbs.2021.05.062_b0035","first-page":"229","article-title":"Effectiveness of mandatory transmissible diseases screening in Indian blood donors","volume":"101","author":"Choudhury","year":"1995","journal-title":"Indian J. Med. Res."},{"issue":"1 Suppl","key":"10.1016\/j.sjbs.2021.05.062_b0040","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jhep.2014.06.031","article-title":"Virology and cell biology of the hepatitis C virus life cycle: an update","volume":"61","author":"Dubuisson","year":"2014","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.sjbs.2021.05.062_b0045","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.9.30476","article-title":"Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions","volume":"22","author":"Duffell","year":"2017","journal-title":"Euro. Surveill."},{"issue":"11","key":"10.1016\/j.sjbs.2021.05.062_b0050","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/aje\/kwq299","article-title":"Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study","volume":"172","author":"Edgren","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"13","key":"10.1016\/j.sjbs.2021.05.062_b0055","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.sjbs.2021.05.062_b0060","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.tim.2015.07.007","article-title":"Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus","volume":"23","author":"Fukuhara","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.sjbs.2021.05.062_b0065","first-page":"201","article-title":"Do blood groups have a biological role","author":"Garratty","year":"1994","journal-title":"Immunobiol. Transfus. Med."},{"issue":"4","key":"10.1016\/j.sjbs.2021.05.062_b0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/tmrv.2000.16228","article-title":"Blood groups and disease: a historical perspective","volume":"14","author":"Garratty","year":"2000","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.sjbs.2021.05.062_b0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0065-3527(08)00002-X","article-title":"Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems","volume":"71","author":"Gottwein","year":"2008","journal-title":"Adv. Virus Res."},{"issue":"7","key":"10.1016\/j.sjbs.2021.05.062_b0095","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1023\/A:1024887211146","article-title":"The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India","volume":"18","author":"Jain","year":"2003","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.sjbs.2021.05.062_b0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.sjbs.2021.05.062_b0105","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/0035-9203(81)90149-8","article-title":"ABO blood groups in relation to hepatitis-B surface antigen (Australia antigen)","volume":"75","author":"Lenka","year":"1981","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"10","key":"10.1016\/j.sjbs.2021.05.062_b0110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrmicro3098","article-title":"The ins and outs of hepatitis C virus entry and assembly","volume":"11","author":"Lindenbach","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"issue":"9635","key":"10.1016\/j.sjbs.2021.05.062_b0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(08)61116-2","article-title":"Acute hepatitis C","volume":"372","author":"Maheshwari","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.sjbs.2021.05.062_b0120","first-page":"123","article-title":"Prevalence of hepatitis C virus antibody in healthy blood donors","volume":"110","author":"Makroo","year":"1999","journal-title":"Indian J. Med. Res."},{"issue":"21","key":"10.1016\/j.sjbs.2021.05.062_b0125","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group","volume":"339","author":"McHutchison","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.sjbs.2021.05.062_b0130","unstructured":"Organization, W.H., 2017. Global Hepatitis Report 2017, World Health Organization."},{"issue":"3","key":"10.1016\/j.sjbs.2021.05.062_b0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.sjbs.2021.05.062_b0145","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s10620-006-9121-5","article-title":"Association between ABO blood group and fibrosis severity in chronic hepatitis C infection","volume":"51","author":"Poujol-Robert","year":"2006","journal-title":"Dig. Dis. Sci."},{"issue":"Suppl","key":"10.1016\/j.sjbs.2021.05.062_b0150","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.26719\/2010.16.Supp.15","article-title":"Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures","volume":"16","author":"Qureshi","year":"2010","journal-title":"East Mediterr. Health J."},{"issue":"12","key":"10.1016\/j.sjbs.2021.05.062_b0155","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/aje\/kws458","article-title":"ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis","volume":"177","author":"Risch","year":"2013","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.sjbs.2021.05.062_b0160","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0891-5520(05)70130-6","article-title":"Viral hepatitis in the liver transplant recipient","volume":"14","author":"Rosen","year":"2000","journal-title":"Infect. Dis. Clin. North Am."},{"issue":"7","key":"10.1016\/j.sjbs.2021.05.062_b0165","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm.3248","article-title":"Understanding the hepatitis C virus life cycle paves the way for highly effective therapies","volume":"19","author":"Scheel","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.sjbs.2021.05.062_b0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1099\/jgv.0.000672","article-title":"ICTV Virus Taxonomy Profile: Flaviviridae","volume":"98","author":"Simmonds","year":"2017","journal-title":"J. Gen. Virol."},{"issue":"10049","key":"10.1016\/j.sjbs.2021.05.062_b0175","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013","volume":"388","author":"Stanaway","year":"2016","journal-title":"Lancet"},{"issue":"38","key":"10.1016\/j.sjbs.2021.05.062_b0180","doi-asserted-by":"crossref","first-page":"10790","DOI":"10.3748\/wjg.v21.i38.10790","article-title":"Epidemiology of hepatitis C virus in Iran","volume":"21","author":"Taherkhani","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.sjbs.2021.05.062_b0185","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"20","key":"10.1016\/j.sjbs.2021.05.062_b0190","first-page":"761","article-title":"Pancreatic cancer and ABO blood types: a study of cases and controls","volume":"96","author":"Vioque","year":"1991","journal-title":"Med. Clin. (Barc.)"},{"issue":"4","key":"10.1016\/j.sjbs.2021.05.062_b0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000151129","article-title":"\u00dcBER DIE POPULATIONSGENETIK DER ABO-BLUTGRUPPEN","volume":"10","author":"Vogel","year":"1960","journal-title":"Hum. Hered."},{"key":"10.1016\/j.sjbs.2021.05.062_b0200","unstructured":"World Health, O., 2016. Combating Hepatitis B and C to Reach Elimination by 2030: Advocacy Brief. World Health Organization, Geneva."}],"container-title":["Saudi Journal of Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X21004411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X21004411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:08:49Z","timestamp":1761152929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319562X21004411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1319562X21004411"],"URL":"https:\/\/doi.org\/10.1016\/j.sjbs.2021.05.062","relation":{},"ISSN":["1319-562X"],"issn-type":[{"value":"1319-562X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of blood groups with hepatitis C viremia","name":"articletitle","label":"Article Title"},{"value":"Saudi Journal of Biological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjbs.2021.05.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}